Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Qiagen NV (QGEN.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-30	50.14	55.00	Neutral
2022-04-29	45.37	52.00	Neutral
2022-11-08	44.28	50.00	Neutral
2023-02-08	49.37	52.00	Neutral
2023-05-04	46.04	50.00	Neutral
2023-08-08	44.60	48.00	Neutral
2023-10-31	37.43	42.00	Neutral
2024-01-02	43.65	44.00	Neutral
2024-06-17	43.73	46.00	Neutral
2024-08-01	45.80	50.00	Neutral
2025-02-06	42.44	48.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
Because this company is an announced takeout candidate, UBS believes the security presents lower-than-normal risk. We have widened its rating band to +6%/-10% compared with +6%/-6%, respectively, under the normal rating system.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.